Luspatercept Mitigates Anemia in Lower-Risk Myelodysplastic Syndromes

WEDNESDAY, Jan. 8, 2020 -- For patients with lower-risk myelodysplastic syndromes with ring sideroblasts who have been receiving regular red-cell transfusions, luspatercept reduces the severity of anemia compared with placebo, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news